- 37
- 38 165
Newcells Biotech
Registrace 10. 03. 2020
Newcells is an innovative drug discovery partner, specialising in de-risking your decisions through market-leading in vitro models that accurately predict in vivo outcomes to improve clinical translation.
Video
Dr Mike Nicholds - How Newcells Works With Clients
zhlédnutí 76Před 4 měsíci
Dr Mike Nicholds - How Newcells Works With Clients
Newcells Biotech - Lung Model Capabilities
zhlédnutí 32KPřed 7 měsíci
Discover more about our lung platform and how we can accelerate your pre-clinical research.
Meet Dr Megan Webster - our Head of Lung Development
zhlédnutí 694Před 8 měsíci
Exploring the innovation behind our lung platforms
Newcells Biotech - Retinal Model Capabilities
zhlédnutí 129Před 10 měsíci
Find out more about our retinal model capabilities at Newcells
Newcells Biotech's MPS Flow technology
zhlédnutí 140Před 11 měsíci
An explanation of our MPS Flow technology which can be used for a myriad of different applications.
Meet Dr Valeria Chichagova - our Associate Director of iPSC technology and Head of Retina
zhlédnutí 1KPřed 11 měsíci
Explaining about the goals of the retina team and our models,
Retinal organoids as a tool for in vitro pre-clinical testing
zhlédnutí 69Před rokem
IPSC-derived retinal organoids are an emerging in vitro tool for various applications They have a potential of being used in efficacy and safety screens of new compounds and for disease modelling applications They are increasingly showing utility in gene therapy applications and can be used for testing novel gene therapy vectors and investigating optimal doses, therapeutic potential and s...
Introducing our Fibroblast-to-Myofibroblast Transition (FMT) Assay
zhlédnutí 379Před rokem
Newcells offers a fast and reliable FMT assay to evaluate the efficacy of anti-fibrotic compounds using high-content imaging. This customisable, high-throughput assay is well suited to compound screening for small molecules targeting lung fibrosis. In the fibrotic lung normal repair processes are defective.
Revival of aProximate™ Assay Ready Plates
zhlédnutí 135Před rokem
Revival of aProximate™ Assay Ready Plates
Newcells retinal organoids as an in vitro tool for preclinical testing of gene therapy vectors
zhlédnutí 180Před 2 lety
Newcells retinal organoids as an in vitro tool for preclinical testing of gene therapy vectors
Kidney as a Target: The Important Role of SLCs (Sodium Linked Co-Transporters)
zhlédnutí 60Před 2 lety
Kidney as a Target: The Important Role of SLCs (Sodium Linked Co-Transporters)
Newcells Retinal Organoids with our Senior Scientist Dr Carolina Gándara
zhlédnutí 163Před 2 lety
Newcells Retinal Organoids with our Senior Scientist Dr Carolina Gándara
Newcells Retinal Organoids with our Associate Scientist George Buchanan
zhlédnutí 437Před 2 lety
Newcells Retinal Organoids with our Associate Scientist George Buchanan
Why do iPSCs have the potential to change drug discovery?
zhlédnutí 54Před 2 lety
Why do iPSCs have the potential to change drug discovery?
Why should Newcells be considered as a partner of choice in drug discovery?
zhlédnutí 95Před 2 lety
Why should Newcells be considered as a partner of choice in drug discovery?
How to unpack and plate Retinal Organoids upon delivery
zhlédnutí 252Před 2 lety
How to unpack and plate Retinal Organoids upon delivery
The kidney as a therapeutic target: Targeting Therapeutics to the Proximal Tubule
zhlédnutí 144Před 2 lety
The kidney as a therapeutic target: Targeting Therapeutics to the Proximal Tubule
Retinal Organoids as an Emerging Tool for Drug Discovery
zhlédnutí 196Před 2 lety
Retinal Organoids as an Emerging Tool for Drug Discovery
How Newcells retinal organoids could be used in ophthalmic retinopathy research
zhlédnutí 66Před 2 lety
How Newcells retinal organoids could be used in ophthalmic retinopathy research
A human iPSC-derived model of SARS-CoV-2 infection and pathogenesis in the lung
zhlédnutí 74Před 2 lety
A human iPSC-derived model of SARS-CoV-2 infection and pathogenesis in the lung
Reducing compound attrition by predicting renal tubular toxicity with in vitro PTEC models
zhlédnutí 39Před 2 lety
Reducing compound attrition by predicting renal tubular toxicity with in vitro PTEC models
Human induced pluripotent stem cell (hiPSC)-derived retinal model containing microglial cells
zhlédnutí 92Před 2 lety
Human induced pluripotent stem cell (hiPSC)-derived retinal model containing microglial cells
Way to go Megan, let me know if you need any HBE cells 😉
Amazing story, amazing achievements, amazing person